Mr. Dew (65) was appointed a Non-Executive Director of the Company on 17 December 2002 and became an Executive Director and the Deputy Chairman of the Company on 13 February 2003. He was appointed the Chairman of the Company on 18 March 2003. With effect from 1 July 2007, he was re-designated to Non-Executive Chairman of the Company. Mr. Dew graduated from the Law School of the University of Sydney, Australia, and was admitted as a solicitor and later as a barrister of the Supreme Court of New South Wales, Australia. He is currently a non-practising barrister. He has a broad range of corporate and business experience and has served as a director, and in some instances chairman of the board of directors, of a number of public companies listed in Australia, Hong Kong and elsewhere. He is a non-executive director and the chairman of Allied Group Limited (：Allied Group；) and Allied Properties (H.K.) Limited (：Allied Properties；), ultimate holding company and holding company of the Company respectively. He was appointed a director of Sun Hung Kai & Co. Limited (：SHK；), holding company of the Company, in June 1996 and resigned in December 2006. Allied Group, Allied Properties and SHK are companies listed on The Stock Exchange of Hong Kong Limited (the ：Stock Exchange；).

Dr. Chee (42) was appointed an Alternate Director in March 2003 and subsequently an Executive Director of the Company on 6 June 2003. With effect from 1 July 2007, he was appointed the Chief Executive Officer of the Company. He graduated with a Bachelor of Medicine and Bachelor of Surgery Degree (MBBS) from National University of Singapore and completed his training as a Ear, Nose and Throat Surgeon. Dr. Chee is a Fellow of the Royal College of Surgeons Edinburgh, Fellow of the Academy of Medicine Singapore and Fellow of the American Academy of Otorhinolargyngology and Head and Neck Surgery. He was sponsored by the Singapore Government to complete a clinical fellowship in Rhinology at the University of Iowa Hospitals and Clinics ENT Programme. Dr. Chee was a consultant surgeon with Singapore General Hospital and a clinical lecturer in National University of Singapore. He has published in prestigious peer reviewed journals and conducted international courses in Endoscopic Sinus Surgery. Dr. Chee has also attended executive education courses for healthcare at Harvard Business School and finance at Michigan Ross School of Business. With 18 years of healthcare experience, Dr. Chee has been active at management and strategy planning at the Group. Since his appointment to the Board, he has been the managing director of Quality HealthCare Medical Services.

Mr. Wong (42) was appointed an Executive Director of the Company on 5 April 2000. He joined the Group in 1997 and is also the Finance Director of the Group and heads the Quality HealthCare Elderly Division. Prior to joining the Group, Mr. Wong had been the financial controller of other listed companies in Hong Kong. Mr. Wong has a Master・s Degree in Business Administration and is a fellow of both the Hong Kong Institute of Certified Public Accountants and the Association of Chartered Certified Accountants and a Chartered Secretary.

Mr. Chang (52) was appointed an Independent Non-Executive Director of the Company on 28 October 2004 and became the Deputy Chairman of the Company on 24 November 2006. Mr. Chang is a registered person under the Securities and Futures Ordinance and since 2000 has been the managing director of Ceres Capital Limited. He has over 29 years of experience in banking, corporate finance, investment and management. Mr. Chang holds a Bachelor・s Degree in Commerce from Concordia University in Montreal, Canada since 1976 and a Master・s Degree in Business Administration from York University in Toronto, Canada since 1977. He is currently an executive director of Golden 21 Investment Holdings Limited and Trasy Gold Ex Limited; and an independent non-executive director of Tian An China Investments Company Limited and Chitaly Holdings Limited, all are companies listed on the Stock Exchange.

Mr. Li (42) was appointed an Independent Non-Executive Director of the Company on 12 October 2004. He holds a Bachelor・s Degree of Business Administration and is a member of the Hong Kong Institute of Certified Public Accountants and a fellow member of The Association of Chartered Certified Accountants in the United Kingdom. He has over 18 years・ experience in auditing, accounting and financial management. Mr. Li is also an independent non-executive director of Shanghai Allied Cement Limited, The Hong Kong Building and Loan Agency Limited and Smart Union Group (Holdings) Limited, all are companies listed on the Stock Exchange.

Mr. Procter (66) was appointed an Independent Non-Executive Director of the Company on 30 September 2004. He graduated from the University of Sydney, Australia with a Bachelor・s Degree and a Master・s Degree in Economics. He is a Fellow of the Financial Services Institute of Australasia (FFin.). Based in Australia, Mr. Procter worked in the Reserve Bank of Australia for over 30 years, holding various senior management positions. Since leaving the Bank, he has worked as a consultant to the International Monetary Fund (IMF) and the Asian Development Bank (ADB) and has also undertaken private consulting work in the Philippines, Indonesia and Papua New Guinea in the areas of bank supervision, anti-money laundering and corporate governance respectively. Mr. Procter is currently a non-executive director of Bank South Pacific Limited, a company listed on the Port Moresby Stock Exchange, and an independent non-executive director of SHK, a company listed on the Stock Exchange and the holding company of the Company.